A - Human Necessities – 01 – N
Patent
A - Human Necessities
01
N
A01N 37/12 (2006.01) A01N 37/44 (2006.01) A61K 31/195 (2006.01) A61K 31/21 (2006.01) A61K 31/22 (2006.01) A61K 31/505 (2006.01) A61K 38/18 (2006.01) A61L 31/16 (2006.01)
Patent
CA 2369772
Vessels are treated with a mixture of L-arginine and an agent which enhances the biotransformation of L-arginine into NO. The incidents associated with restenosis are expected to be substantially reduced and prevented providing for a reduced incidence of restenosis as a result of the injury.
On traite les vaisseaux à l'aide d'un mélange de L-arginine et d'un agent qui stimule la biotransformation de la L-arginine en monoxyde d'azote. On escompte une réduction sensible, sinon une prévention, des incidents associés à la resténose, ce qui diminue l'incidence de la resténose résultant de la lésion.
Angiogenix Inc.
Borden Ladner Gervais Llp
Nitrosystems Inc.
LandOfFree
A therapeutic mixture useful in inhibiting lesion formation... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with A therapeutic mixture useful in inhibiting lesion formation..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A therapeutic mixture useful in inhibiting lesion formation... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1358774